MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus

[1]  A. Ahmadiani,et al.  MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid βeta oligomer induced Alzheimer's like rat model , 2022, Experimental Gerontology.

[2]  Lin Guo,et al.  Aberrant miR-339-5p/neuronatin signaling causes prodromal neuronal calcium dyshomeostasis in mutant presenilin mice , 2022, The Journal of clinical investigation.

[3]  Yi Guo,et al.  Polygenic risk of Alzheimer's disease in the Faroe Islands , 2022, European journal of neurology.

[4]  Lubo Zhang,et al.  MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction , 2022, Circulation.

[5]  Shirong Cao,et al.  Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis , 2022, Molecular cancer.

[6]  A. Abbott.  Could drugs prevent Alzheimer’s? These trials aim to find out , 2022, Nature.

[7]  D. Franco,et al.  Post-Transcriptional Regulation of Molecular Determinants during Cardiogenesis , 2022, International journal of molecular sciences.

[8]  J. Fish,et al.  MicroRNA-Based Regulation of Embryonic Endothelial Cell Heterogeneity at Single-Cell Resolution. , 2022, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Xiaoxin Yan,et al.  Brain-Penetration and Neuron-Targeting DNA Nanoflowers Co-Delivering miR-124 and Rutin for Synergistic Therapy of Alzheimer's Disease. , 2022, Small.

[10]  C. Qi,et al.  MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  B. Winblad,et al.  An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments , 2021, Cell Research.

[12]  Fredrik D. Johansson,et al.  Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease , 2021, Alzheimer's research & therapy.

[13]  A. Alexiou,et al.  DIANA-miTED: a microRNA tissue expression database , 2021, Nucleic Acids Res..

[14]  Baian Chen,et al.  Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease , 2021, Aging cell.

[15]  R. D'Hooge,et al.  Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer's disease. , 2021, Cell stem cell.

[16]  V. Lowe,et al.  Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[17]  Vishal Chavda,et al.  Coding and non-coding nucleotides': The future of stroke gene therapeutics. , 2021, Genomics.

[18]  Qingwei Yang,et al.  Targeting MicroRNA-125b Promotes Neurite Outgrowth but Represses Cell Apoptosis and Inflammation via Blocking PTGS2 and CDK5 in a FOXQ1-Dependent Way in Alzheimer Disease , 2020, Frontiers in Cellular Neuroscience.

[19]  Kyoung-Jin Oh,et al.  The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene , 2020, The Journal of Biological Chemistry.

[20]  Q. Guan,et al.  Mechanism of microRNA‐22 in regulating neuroinflammation in Alzheimer’s disease , 2020, Brain and behavior.

[21]  Filip Kosel,et al.  Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology , 2020, Neuroscience & Biobehavioral Reviews.

[22]  N. Zhang,et al.  MiR-22-3p regulates amyloid β deposit in mice model of Alzheimer's disease by targeting mitogen-activated protein kinase 14. , 2019, Current neurovascular research.

[23]  Tatsuhiko Tsunoda,et al.  A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression data , 2019, BMC Medical Genomics.

[24]  R. Perneczky,et al.  Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid , 2019, Alzheimer's & Dementia.

[25]  Y. Levin,et al.  Suspension Trapping (S-Trap) Is Compatible with Typical Protein Extraction Buffers and Detergents for Bottom-Up Proteomics. , 2019, Journal of proteome research.

[26]  J. Hong,et al.  NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease. , 2019, CNS & neurological disorders drug targets.

[27]  I. Nelken,et al.  Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo , 2018, Nature Neuroscience.

[28]  Weikai Zhang,et al.  Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-κB signaling pathway by targeting SOX9 , 2018, Cancer Gene Therapy.

[29]  Richard Hodson.  Alzheimer’s disease , 2018, Nature.

[30]  K. Döhner,et al.  Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Ron Brookmeyer,et al.  Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States , 2018, Alzheimer's & Dementia.

[32]  J. McLaurin,et al.  The role of the immune system in Alzheimer disease: Etiology and treatment , 2017, Ageing Research Reviews.

[33]  Yanxin Zhao,et al.  β-amyloid increases neurocan expression through regulating Sox9 in astrocytes: A potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease , 2016, Brain Research.

[34]  A. Najafi,et al.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. , 2016, Brain : a journal of neurology.

[35]  M. Kanehisa,et al.  BlastKOALA and GhostKOALA: KEGG Tools for Functional Characterization of Genome and Metagenome Sequences. , 2016, Journal of molecular biology.

[36]  Minmin Shi,et al.  Proteomic Analysis of Solid Pseudopapillary Tumor of the Pancreas Reveals Dysfunction of the Endoplasmic Reticulum Protein Processing Pathway* , 2014, Molecular & Cellular Proteomics.

[37]  J. Pothof,et al.  MicroRNA-Mediated Down-Regulation of M-CSF Receptor Contributes to Maturation of Mouse Monocyte-Derived Dendritic Cells , 2013, Front. Immunol..

[38]  S. Watowich,et al.  miR-22 Controls Irf8 mRNA Abundance and Murine Dendritic Cell Development , 2012, PloS one.

[39]  M. Saegusa,et al.  Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway. , 2012, The American journal of pathology.

[40]  C. Cotman,et al.  Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study , 2012, Journal of Neuroinflammation.

[41]  N. Yamashita,et al.  Profiling of immune‐related microRNA expression in human cord blood and adult peripheral blood cells upon proinflammatory stimulation , 2012, European journal of haematology.

[42]  F. Gage,et al.  Adult hippocampal neurogenesis and its role in Alzheimer's disease , 2011, Molecular Neurodegeneration.

[43]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[44]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[45]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[46]  M. Hofker.  Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. , 2003 .

[47]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[48]  F. Gage,et al.  Functional neurogenesis in the adult hippocampus , 2002, Nature.

[49]  Guiquan Chen,et al.  A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.

[50]  J. Testa,et al.  A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. , 1991, Science.

[51]  Chunxiao Wu,et al.  A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[52]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[53]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..